Q4 2024 Earnings Call Transcript March 31, 2025 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.07. Operator: Good afternoon, ladies and gentleman ...

We are focused initially on the blood thinner, Brilinta, in patients undergoing coronary artery bypass ... Our product gross margin remained healthy at 71% reflecting the strength of our ...

We were focused initially on the blood thinner Berlinta in patients undergoing coronary artery bypass ... Our product gross margin remained healthy at 71%, reflecting the strength of our ...

That's because an abnormal gene from one parent overrides the normal gene from the other ... Hypercholesterolemia [HeFH] or premature coronary artery disease, the company is in the process ...

with a structurally (gross and histologically) normal heart at autopsy or negative diagnostic findings after survival. Notably, in the age group ≤35 years 7 of 14 confirmed diagnoses of coronary ...

BACKGROUND: Shared genetic and lifestyle risk factors may underlie the development of both coronary artery disease (CAD) and dementia. We examined whether an increased genetic risk for CAD is ...

Discover why remnant cholesterol, not LDL, is key to peripheral artery disease. Learn implications for prevention.

You don't let “freakdom” become “normal.” The Roman Praetorian Guard knew this and killed the perverted freaks Caligula and Nero before they could damage the whole Roman Empire too severely.

Several transcription factors in developing neurons exhibit broad-to-restricted expression patterns, but the relevance of ...

The study shows that, compared with lean animals, obesity significantly impacts echocardiographic findings, infarct size, circulating biomarkers, mitochondrial respiratory capacity and mortality ...